Open tender · Germany · Pharmaceutical products
Arzneimittel mit dem Wirkstoff Rivaroxaban (ATC: B01AF01 - in allen Wirkstärken außer 2,5 mg je abgeteilte orale Darreichungsform)
In EnglishMedicines with the active ingredient Rivaroxaban (ATC: B01AF01 - in all strengths except 2.5 mg per divided oral dosage form)
AOK Sachsen - Anhalt in Germany is inviting bids for “Medicines with the active ingredient Rivaroxaban (ATC: B01AF01 - in all strengths except 2.5 mg per divided oral dosage form)”. Bids close on 31 July 2027, 00:00 CEST. askTender lists every requirement to qualify and checks whether your company meets them.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences